Evidence map›Paper›PMID 24103319›Full record

ArticleThe Libyan journal of medicine2013

Rose geranium essential oil as a source of new and safe anti-inflammatory drugs.

Mohamed Nadjib Boukhatem, Abdelkrim Kameli, Mohamed Amine Ferhat, Fairouz Saidi, Maamar Mekarnia

Abstract read
In one paragraph

Article in The Libyan journal of medicine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. A New Eucalyptol-Rich Lavender (Molecules (Basel, Switzerland) · 2020
    Article
  15. Article
  16. Article
  17. Article
  18. Analgesic-Like Activity of Essential Oil Constituents: An Update.International journal of molecular sciences · 2017
    Review
  19. Chemical composition analysis andBiochimie open · 2017
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mohamed Nadjib BoukhatemLaboratoire Eco-Physiologie Végétale, Département des Sciences Naturelles, Ecole Normale Supérieure de Kouba, Alger, Algeria; Laboratoire Biotechnologies Végétales, Département de Biologie, Université Saad Dahleb de Blida, Algeria; mn.boukhatem@yahoo.fr.
Abdelkrim Kameli
Mohamed Amine Ferhat
Fairouz Saidi
Maamar Mekarnia

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSince the available anti-inflammatory drugs exert an extensive variety of side effects, the search for new anti-inflammatory agents has been a priority of pharmaceutical industries.

aimsThe aim of the present study was to assess the anti-inflammatory activities of the essential oil of rose geranium (RGEO).

methodsThe chemical composition of the RGEO was investigated by gas chromatography. The major components were citronellol (29.13%), geraniol (12.62%), and citronellyl formate (8.06%). In the carrageenan-induced paw edema, five different groups were established and RGEO was administered orally in three different doses.

resultsRGEO (100 mg/kg) was able to significantly reduce the paw edema with a comparable effect to that observed with diclofenac, the positive control. In addition, RGEO showed a potent anti-inflammatory activity by topical treatment in the method of croton oil-induced ear edema. When the dose was 5 or 10 µl of RGEO per ear, the inflammation was reduced by 73 and 88%, respectively. This is the first report to demonstrate a significant anti-inflammatory activity of Algerian RGEO. In addition, histological analysis confirmed that RGEO inhibited the inflammatory responses in the skin.

conclusionOur results indicate that RGEO may have significant potential for the development of novel anti-inflammatory drugs with improved safety profile.

Indexed as

PhytotherapyAcyclic MonoterpenesAnimalsAnti-Inflammatory AgentsChromatography, GasEdemaGeraniumHindlimbMaleMiceMonoterpenesOils, VolatilePlant PreparationsRosaSkinTerpenesAcyclic MonoterpenesAnti-Inflammatory Agentscitronellolcitronellyl formategeraniolMonoterpenesOils, VolatilePlant PreparationsTerpenesanti-inflammatory effectcarrageenancitronellolcrotonessential oilshistopathologyrose geraniumskin inflammation

Identifiers

PMID24103319
PMCPMC3793238

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.